Results 91 to 100 of about 192,978 (193)

Intervening Early in the Cardiovascular-Kidney-Metabolic Syndrome: Expert Recommendations from the United Arab Emirates on the Management of Prediabetes. [PDF]

Vasc Health Risk Manag
Abusnana S, Sabbour H, Afandi B, Farghaly MNMH, Farooqi MH, Hafidh K, Hassanein M, Jabbar A, Shehab A, Kalimat R, Brand KMG.   +10 more
europepmc   +1 more source

DASH Diet Adherence and Cardiovascular-Kidney Metabolic Syndrome Stages

JACC: Advances
Chelsea Akubo, India E. Washington, Shanshan Song, Maya Kramer-Johansen, Christy Rodriguez, Mojisola Olusola-Bello, Samuel Gledhill, Valerie Sullivan, Yvonne Commodore-Mensah, Oluwabunmi Ogungbe   +9 more
openaire   +1 more source

Air pollution promotes the onset and progression of cardiovascular-kidney-metabolic syndrome: a nationwide prospective cohort study. [PDF]

BMC Public Health
Gui C, Xiao Z, Li M, Xu J.
europepmc   +1 more source

Rest-activity rhythms and cardiovascular events in cardiovascular-kidney-metabolic syndrome: evidence from two nationwide cohorts. [PDF]

Am J Prev Cardiol
Weng B, Chen H, Chen H, Wang N, Feng H, Yang K, Tan X.   +6 more
europepmc   +1 more source

The Role of Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Cardiovascular-Kidney-Metabolic Syndrome. [PDF]

JACC Adv
Kumar S, Anderson JE, Coviello A, Lopez-Jimenez F, Bakris GL.   +4 more
europepmc   +1 more source

Cardiovascular–Kidney–Metabolic Syndrome: Untangling the Interconnected Burden

Indian Journal of Kidney Diseases
openaire   +1 more source

Clonal Haematopoiesis and Cardiovascular-Kidney-Metabolic Syndrome: Emerging Links

Heart, Lung and Circulation
Savindi Wimalarathne, Nick S.R. Lan, Leon A. Adams, Girish Dwivedi   +3 more
openaire   +1 more source

Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKM. [PDF]

Am J Prev Cardiol
Miller M, Bhatt DL, Brinton EA, Jacobson TA, Steg PG, Ketchum SB, Pineda AL, Tardif JC, Ballantyne CM, REDUCE-IT Investigators*.   +9 more
europepmc   +1 more source